These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16236510)

  • 21. Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.
    Kazuta Y; Hirano K; Natsume K; Yamada S; Kimura R; Matsumoto S; Furuichi K; Matsuda A; Shuto S
    J Med Chem; 2003 May; 46(10):1980-8. PubMed ID: 12723960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N,N-Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: a novel, exceptionally selective, potent delta opioid receptor agonist with oral bioavailability and its analogues.
    Wei ZY; Brown W; Takasaki B; Plobeck N; Delorme D; Zhou F; Yang H; Jones P; Gawell L; Gagnon H; Schmidt R; Yue SY; Walpole C; Payza K; St-Onge S; Labarre M; Godbout C; Jakob A; Butterworth J; Kamassah A; Morin PE; Projean D; Ducharme J; Roberts E
    J Med Chem; 2000 Oct; 43(21):3895-905. PubMed ID: 11052794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors.
    Xie SX; Kraus A; Ghorai P; Ye QZ; Elz S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1262-8. PubMed ID: 16554355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacological characterization of 5-phenyl-2-[2-(1-piperidinylcarbonyl)phenyl]-2,3-dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones: a new class of Neuropeptide S antagonists.
    Micheli F; Di Fabio R; Giacometti A; Roth A; Moro E; Merlo G; Paio A; Merlo-Pich E; Tomelleri S; Tonelli F; Zarantonello P; Zonzini L; Capelli AM
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7308-11. PubMed ID: 21055936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation.
    Wei RG; Adler M; Davey D; Ho E; Mohan R; Polokoff M; Tseng JL; Whitlow M; Xu W; Yuan S; Phillips G
    Bioorg Med Chem Lett; 2007 May; 17(9):2499-504. PubMed ID: 17368901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; Herbertz T; Yap GP; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7278-89. PubMed ID: 17149858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further studies of tyrosine surrogates in opioid receptor peptide ligands.
    Dolle RE; Michaut M; Martinez-Teipel B; Belanger S; Graczyk TM; DeHaven RN
    Bioorg Med Chem Lett; 2007 May; 17(9):2656-60. PubMed ID: 17350835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly potent and selective zwitterionic agonists of the delta-opioid receptor. Part 1.
    Middleton DS; Maw GN; Challenger C; Jessiman A; Johnson PS; Million WA; Nichols CL; Price JA; Trevethick M
    Bioorg Med Chem Lett; 2006 Feb; 16(4):905-10. PubMed ID: 16290934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N,N-dialkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, potent, selective delta opioid agonists.
    Carson JR; Coats SJ; Codd EE; Dax SL; Lee J; Martinez RP; Neilson LA; Pitis PM; Zhang SP
    Bioorg Med Chem Lett; 2004 May; 14(9):2109-12. PubMed ID: 15080989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.
    Peng X; Knapp BI; Bidlack JM; Neumeyer JL
    J Med Chem; 2006 Jan; 49(1):256-62. PubMed ID: 16392810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and in vitro characterization of N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8- tetrahydronaphthalen-1-yl]methanesulfonamide and its enantiomers: a novel selective alpha 1A receptor agonist.
    Meyer MD; Altenbach RJ; Hancock AA; Buckner SA; Knepper SM; Kerwin JF
    J Med Chem; 1996 Sep; 39(20):4116-9. PubMed ID: 8831777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and SAR study of opioid receptor ligands: mono- and bis-indolomorphinans.
    Li F; Yin C; Chen J; Liu J; Xie X; Zhang A
    Chem Biol Drug Des; 2009 Oct; 74(4):335-42. PubMed ID: 19691470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists.
    Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A selective human H(4)-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R)-5- [1H-imidazol-4(5)-yl]tetrahydrofuran-2-y] methylguanidine.
    Hashimoto T; Harusawa S; Araki L; Zuiderveld OP; Smit MJ; Imazu T; Takashima S; Yamamoto Y; Sakamoto Y; Kurihara T; Leurs R; Bakker RA; Yamatodani A
    J Med Chem; 2003 Jul; 46(14):3162-5. PubMed ID: 12825954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-Piperidin-4-ylidenemethyl-benzamides as δ-opioid receptor agonists for CNS indications: identifying clinical candidates.
    Dantzman CL; King MM; Ernst GE; Wang X; McCauley JP; Andisik DW; Brush K; Bui KH; Frietze W; Hoesch V; Liu J; Palmer WE; Spear N; Hudzik TJ; Wesolowski SS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1174-8. PubMed ID: 22197137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.
    Kumar V; Guo D; Cassel JA; Daubert JD; Dehaven RN; Dehaven-Hudkins DL; Gauntner EK; Gottshall SL; Greiner SL; Koblish M; Little PJ; Mansson E; Maycock AL
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1091-5. PubMed ID: 15686919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-alkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, micro and delta opioid agonists: a micro address.
    Carson JR; Coats SJ; Codd EE; Dax SL; Lee J; Martinez RP; McKown LA; Anne Neilson L; Pitis PM; Wu WN; Zhang SP
    Bioorg Med Chem Lett; 2004 May; 14(9):2113-6. PubMed ID: 15080990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationships of a new series of 2alpha-substituted trans-4,5-dimethyl-4-(3-hydroxyphenyl)piperidine as mu-selective opioid antagonists.
    Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; DeHaven RN; Dolle RE
    Bioorg Med Chem Lett; 2006 Feb; 16(4):864-8. PubMed ID: 16298525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly potent and selective phenylmorphan-based inverse agonists of the opioid delta receptor.
    Thomas JB; Zhang L; Navarro HA; Carroll FI
    J Med Chem; 2006 Sep; 49(18):5597-609. PubMed ID: 16942033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.